ZBIO

ZBIO R&D to Revenue

1680.63%Fiscal year

Period ending:

ZBIO FY R&D/Revenue%
ZBIO FY R&D/Revenue3116.71%-333.93%
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ZBIO r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Zenas Biopharma Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
1,680.63%
2,782.78%
120.066%
0%

Compare r&d to revenue

All ZBIO financial metrics · ZBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.